All Stories

  1. Inhibition of FGF in muscle inflammatory diseases

    Article • F1000Research, January 2016, Faculty of 1000, Ltd.

    Prof Guillermo Gimenez-Gallego

  2. Discovery and Characterization of an Endogenous CXCR4 Antagonist

    Article • Cell Reports, May 2015, Elsevier

    Dr Halvard B Bonig, Prof Guillermo Gimenez-Gallego

  3. Inhibition of FGF in ocular inflammatory diseases

    Article • F1000Research, December 2013, Faculty of 1000, Ltd.

    Prof Guillermo Gimenez-Gallego, Luis Outeirino Miguez

  4. Durable recovery of the macular architecture and functionality of a diagnosed age-related macular degeneration 1 year after a single intravitreal injection of dobesilate

    Article • BMJ Case Reports, November 2013, BMJ

    Prof Guillermo Gimenez-Gallego

  5. Dobesilate for dry age-related macular degeneration

    Article • Journal of Biomedical Science and Engineering, January 2013, Scientific Research Publishing, Inc,

    Prof Guillermo Gimenez-Gallego

  6. Treatment of Stargardt disease with dobesilate

    Article • BMJ Case Reports, October 2012, BMJ

    Prof Guillermo Gimenez-Gallego

  7. Intravitreal dobesilate in the treatment of choroidal neovascularisation associated with age-related macular degeneration: report of two cases

    Article • BMJ Case Reports, September 2012, BMJ

    Prof Guillermo Gimenez-Gallego

  8. Chronic cystoid macular oedema treated with intravitreal dobesilate

    Article • BMJ Case Reports, July 2012, BMJ

    Prof Guillermo Gimenez-Gallego

  9. Treatment of dry age-related macular degeneration with dobesilate

    Article • BMJ Case Reports, June 2012, BMJ

    Prof Guillermo Gimenez-Gallego

  10. Clearance of seborrhoeic keratoses with topical dobesilate

    Article • BMJ Case Reports, June 2012, BMJ

    Prof Guillermo Gimenez-Gallego

  11. Short-term efficacy of intravitreal dobesilate in central serous chorioretinopathy

    Article • European Journal of Medical Research, January 2012, Springer Science + Business Media

    Prof Guillermo Gimenez-Gallego

  12. Inhibition of vascular endothelial growth factor (VEGF)-induced endothelial proliferation, arterial relaxation, vascular permeability and angiogenesis by dobesilate

    Article • European Journal of Pharmacology, September 2011, Elsevier

    Prof Guillermo Gimenez-Gallego

  13. Topical treatment of contact dermatitis by pine processionary caterpillar

    Article • BMJ Case Reports, August 2011, BMJ

    Prof Guillermo Gimenez-Gallego

  14. Efficacy of the fibroblast growth factor inhibitor 2,5-dihydroxyphenylsulfonate in basal cell carcinoma: A histopathological and inmunohistochemical study

    Article • Journal of Dermatological Treatment, July 2011, Taylor & Francis

    Prof Guillermo Gimenez-Gallego

  15. Antiglioma effects of a new, low molecular mass, inhibitor of fibroblast growth factor

    Article • Neuroscience Letters, March 2011, Elsevier

    Prof Guillermo Gimenez-Gallego

  16. Short-Term Monotherapy in HIV-Infected Patients with a Virus Entry Inhibitor Against the gp41 Fusion Peptide

    Article • Science Translational Medicine, December 2010, American Association for the Advancement of Science

    Prof Guillermo Gimenez-Gallego

  17. Gentisic Acid, a Compound Associated with Plant Defense and a Metabolite of Aspirin, Heads a New Class of in Vivo Fibroblast Growth Factor Inhibitors

    Article • Journal of Biological Chemistry, February 2010, American Society for Biochemistry & Molecular Biology (ASBMB)

    Prof Guillermo Gimenez-Gallego

  18. Semen-Derived Amyloid Fibrils Drastically Enhance HIV Infection

    Article • Cell, December 2007, Elsevier

    Prof Guillermo Gimenez-Gallego

  19. Leads for Development of New Naphthalenesulfonate Derivatives with Enhanced Antiangiogenic Activity: CRYSTAL STRUCTURE OF ACIDIC FIBROBLAST GROWTH FACTOR IN COMPLEX WITH 5-AMINO-2-NAPHTHALENESULFONATE

    Article • Journal of Biological Chemistry, April 2003, American Society for Biochemistry & Molecular Biology (ASBMB)

    Prof Guillermo Gimenez-Gallego, Dr Ernesto Quesada

  20. 1 H NMR Structural Characterization of a Nonmitogenic, Vasodilatory, Ischemia-Protector and Neuromodulatory Acidic Fibroblast Growth Factor †

    Article • Biochemistry, May 2000, American Chemical Society (ACS)

    Prof Guillermo Gimenez-Gallego

  21. Solution structure of acidic fibroblast growth factor bound to 1,3,6-naphthalenetrisulfonate: A minimal model for the anti-tumoral action of suramins and suradistas 1 1Edited by P. E. Wright

    Article • Journal of Molecular Biology, September 1998, Elsevier

    Prof Guillermo Gimenez-Gallego

  22. Three-Dimensional Structure of Acidic Fibroblast Growth Factor in Solution: Effects of Binding to a Heparin Functional Analog

    Article • Journal of Molecular Biology, November 1996, Elsevier

    Prof Guillermo Gimenez-Gallego

  23. X-ray Structure of Native Full-Length Human Fibroblast-Growth Factor at 0.25-nm Resolution

    Article • European Journal of Biochemistry, October 1996, Wiley

    Prof Guillermo Gimenez-Gallego

  24. 1H-NMR Assignment and Solution Structure of Human Acidic Fibroblast Growth Factor Activated by Inositol Hexasulfate

    Article • Journal of Molecular Biology, September 1994, Elsevier

    Prof Guillermo Gimenez-Gallego

  25. Hypotensive activity of fibroblast growth factor

    Article • Science, November 1991, American Association for the Advancement of Science

    Prof Guillermo Gimenez-Gallego

  26. Purification, sequence, and model structure of charybdotoxin, a potent selective inhibitor of calcium-activated potassium channels.

    Article • Proceedings of the National Academy of Sciences, May 1988, Proceedings of the National Academy of Sciences

    Prof Guillermo Gimenez-Gallego

  27. The complete amino acid sequence of human brain-derived acidic fibroblast growth factor

    Article • Biochemical and Biophysical Research Communications, July 1986, Elsevier

    Prof Guillermo Gimenez-Gallego

  28. Human brain-derived acidic and basic fibroblast growth factors: Amino terminal sequences and specific mitogenic activities

    Article • Biochemical and Biophysical Research Communications, March 1986, Elsevier

    Prof Guillermo Gimenez-Gallego

  29. Brain-derived acidic fibroblast growth factor: complete amino acid sequence and homologies

    Article • Science, December 1985, American Association for the Advancement of Science

    Prof Guillermo Gimenez-Gallego

  30. Pure brain-derived acidic fibroblast growth factor is a potent angiogenic vascular endothelial cell mitogen with sequence homology to interleukin 1.

    Article • Proceedings of the National Academy of Sciences, October 1985, Proceedings of the National Academy of Sciences

    Prof Guillermo Gimenez-Gallego